Journals / Mersin Üniversitesi Sağlık Bilimleri Dergisi / 2019 / Cilt: 12 - Sayı: 3

Donor management of brain death

Beyin ölümünde donör bakımı

Pages
534–541
Publication Date
2019-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These disorders having different importances were investigated by the recent literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Donor management, recently described as “organ management”, is composed by the treatment of the patients diagnosed with brain death in the intensive care unit.
📊
Key Findings & Data:Unless these disorders be treated, the number and the quality of the organs transplanted may decreased.
💡
Conclusion & Impact:These disorders having different importances were investigated by the recent literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:beyin ölümü · dönörler · yoğun bakım

Abstract

Donor management, recently described as “organ management”, is composed by the treatment of the patients diagnosed with brain death in the intensive care unit. In the brain death, hemodynamic, hormonal and inflammatory disorders resulted in cardiac arrest of the donor candidate can be seen. Unless these disorders be treated, the number and the quality of the organs transplanted may decreased. Also, which organ is planned to be transplanted, treatment and care should be directed to this organ. These disorders having different importances were investigated by the recent literature.

Özet

Donör bakımı, son yıllarda “organ yönetimi” olarak adlandırılan yoğun bakımda beyin ölümü tanısı konulmuş hastalara uygulanan tedaviden oluşur. Beyin ölümünde donör adayının kardiak arrestine yol açabilecek hemodinamik, hormonal ve inflamatuvar bozukluklar görülebilir. Bu bozukluklar tedavi edilmezse transplante edilebilecek organ sayısı ve kalitesi düşebilir. Ayrıca donör bakımında hangi organın transplante edilmesi planlanıyorsa ona yönelik tedavi ve bakım uygulanmalıdır. Her biri ayrı öneme sahip bu bozukluklar son literatür taranarak incelenmiştir.

🔖

Cite This Article

SAGÜN, A., DORUK, N. (2019). Donor management of brain death. Mersin Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 12 - Sayı: 3, 534–541. https://ajindex.com/articles/92810

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. KAYNAKLAR1. Xia VW, Braunfeld M. Anesthesia Management of Organ Donors. Anesthesiol Clin. 2017 Sep;35(3):395-406. doi: 10.1016/j.anclin.2017.04.003. 2. Chamorro-Jambrina C, Muñoz-Ramírez MR et al. Organ donor management: Eight common recommendations and actions that deserve reflection. Med Intensiva. 2017 Dec;41(9):559-568. doi: 10.1016/j.medin.2017.01.012. 3. Domínguez-Roldán JM, García-Alfaro C et al. Muerte encefálica: repercusión sobre órganos y tejidos. Med Intensiva. 2009;33:434---41. 4. Souter MJ, Eidbo E. et al. Organ Donor Management: Part 1. Toward a Consensus to Guide Anesthesia Services During Donation After Brain Death. Semin Cardiothorac Vasc Anesth. 2018 Jun;22(2):211-222. doi: 10.1177/1089253217749053. 5. Shemie SD, Ross H. et al. Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential. Can Med Assoc J 2006; 174: S13–30 6. Wood KE,Becker BN et al. Care of the potential donor. N Engl J Med. 2004;351:2730---9. 7. Audibert G, Charpentier C. et al. Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation. 2006;82:1031---6. 8. Bugge JF. Brain death and its implications for management of the potential organ donor. Acta Anaesthesiol Scand. 2009;53:1239---50. 9. Mascia L, Mastromauro I et al. Management to optimize organ procurement in brain dead donors. Minerva Anestesiol. 2009;75:125---33. 10.Dictus C, Vienenkoetter B. et al. Critical care management of potential organ donors: our current standard. Clin Transpl. 2009;23:2---9. 11.Dikdan GS, Mora-Esteves C. et al. Review of randomized clinical trials of donor management and organ preservation in deceased donors: opportunities and issues. Transplantation. 2012;94:425---41. 12. Plurad DS, Bricker S. et al. Arginine vasopressin significantly increases the rate of successful organ procurement in potential donors. Am J Surg. 2012;204:856---60. 13. Cuende N, Miranda B, Ca˜nón JF, Garrido G, Matesanz R. Donor characteristics associated with liver graft survival. Transplanta tion. 2005;79:1445---52. 14. Malinoski DJ, Daly MC. et al. Achieving donor management goals before deceased donor procurement is associated with more organs transplanted per donor. J Trauma. 2011 Oct;71(4):990-5; discussion 996. doi: 10.1097/TA.0b013e31822779e5. 15. Venkateswaran RV, Patchell VB et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg. 2008 Jan;85(1):278-8